J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)
₹2,408.90
Mkt cap
₹38,677 Cr
P/E ratio
53.80
P/B
9.30
Div yield
0.91%
ROE
18.90%
ROCE
25.40%
EPS (TTM)
₹44.78
Book value
₹259
52W range
1,609–2,506
Sector
Healthcare
Price history
Previous close
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]
NSE JBCHEPHARMBSE 506943
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−3.87% from high₹2,409
₹1,609+49.75% from low₹2,506
Current
₹2,408.90
Prev close
₹2,506.00
Day
−3.87%
Price performance
1D
−3.59%
1W
−1.16%
1M
+10.18%
3M
+21.96%
6M
+26.43%
1Y
+48.65%
YTD
+30.18%
Financials
Revenue, profit & margin
P/E ratio
53.8×
JBCHEPHARM is 58% above the sector median of 34.1×
JBCHEPHARM53.8×
Sector median34.1×
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 762 | 896 | 882 | 845 | 862 | 1,004 | 1,001 | 963 | 949 | 1,094 | 1,085 | 1,065 | 904 | |
| Expenses | 599 | 664 | 638 | 621 | 664 | 724 | 730 | 709 | 723 | 793 | 775 | 769 | 703 | |
| Operating Profit | 164 | 232 | 244 | 223 | 198 | 280 | 271 | 255 | 226 | 301 | 310 | 296 | 201 | |
| OPM % | 21% | 26% | 28% | 26% | 23% | 28% | 27% | 26% | 24% | 28% | 29% | 28% | 22% | |
| Other Income | 5 | 6 | 8 | 7 | 17 | 6 | 10 | 8 | 14 | 15 | 15 | 18 | -15 | |
| Interest | 14 | 12 | 10 | 12 | 9 | 6 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | |
| Depreciation | 32 | 31 | 32 | 34 | 41 | 41 | 42 | 42 | 46 | 43 | 44 | 45 | 50 | |
| Profit before tax | 122 | 194 | 209 | 184 | 165 | 240 | 237 | 218 | 193 | 272 | 279 | 267 | 135 | |
| Tax % | 28% | 27% | 28% | 27% | 23% | 26% | 26% | 25% | 25% | 25% | 26% | 26% | 25% | |
| Net Profit | 88 | 142 | 151 | 134 | 126 | 177 | 175 | 162 | 146 | 202 | 208 | 198 | 101 | |
| EPS in Rs | 5.66 | 9.19 | 9.72 | 8.62 | 8.13 | 11.39 | 11.24 | 10.45 | 9.36 | 12.96 | 13.27 | 12.63 | 6.31 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.31% · closed higher next day 26 of last 61
| Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26† | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 10 Aug '23 | 8 Nov '23 | 7 Feb '24 | 18 May '24 | 8 Aug '24◦ | 6 Nov '24◦ | 5 Feb '25 | 14 May '25◦ | 30 Jul '25◦ | 11 Nov '25◦ | 16 Jan '26◦ | 11 May '26◦ |
| Earnings day | −0.01% | +0.65% | +4.33% | +0.99% | −0.88% | −1.11% | −1.63% | +1.63% | −0.75% | −0.49% | +1.19% | −3.35% |
| +1 day | −1.15% | +3.48% | +2.32% | −2.82% | −0.11% | −2.13% | −1.48% | +2.14% | −2.50% | −0.54% | −1.03% | −5.20% |
| +5 days | −1.59% | +3.43% | −2.85% | −2.35% | −0.18% | −10.57% | −6.66% | +4.47% | −5.23% | −4.18% | −1.39% | −1.70% |
| +15 days | +3.14% | +0.53% | −7.25% | +3.08% | +1.18% | −6.47% | −9.43% | +5.38% | −1.95% | −3.55% | +1.00% | −3.13% |
| +30 days | +5.71% | +11.43% | −6.15% | −1.98% | +0.23% | −1.12% | −5.27% | +8.66% | −5.79% | −0.71% | +7.76% | +1.08% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 months| Kind | Value | Ex-date | Record |
|---|---|---|---|
| dividend Dividend - Rs 9.30 Per Share | 9.30 | 29 May '26 | 29 May '26 |
Results analysis
Shareholding
as of Mar 202648.80%Promoter
Promoters48.80%1.25
FIIs16.33%1.45
DIIs21.38%1.97
Public13.48%0.73
Government0.00%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹1,899.00 | 36.07 | 4,55,634 | 0.84% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| DIVISLAB | ₹9,100.00 | 81.09 | 2,41,576 | 0.33% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| TORNTPHARM | ₹4,857.00 | 82.80 | 1,84,745 | 0.78% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| CIPLA | ₹1,385.00 | 31.26 | 1,11,888 | 0.94% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| ZYDUSLIFE | ₹1,120.00 | 22.95 | 1,11,720 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| LAURUSLABS | ₹1,840.00 | 90.93 | 99,417 | 0.11% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| LUPIN | ₹2,110.00 | 16.20 | 96,483 | 0.85% | 1,417 | +16.08% | 8,277 | +32.04% | 29.93% |
| JBCHEPHARM | ₹2,408.90 | 53.83 | 38,677 | 0.91% | 101 | −16.99% | 904 | −4.77% | 25.45% |
| Median: 159 Co. | ₹431.65 | 34.13 | 2,289 | 0.08% | 14 | +29.60% | 166 | +18.62% | 15.04% |
Filings
Annual reports15
Annual Report 2026bseAnnual Report 2025bseAnnual Report 2024bseAnnual Report 2023bseAnnual Report 2022bseAnnual Report 2021bseAnnual Report 2020bseAnnual Report 2019bseAnnual Report 2018bseAnnual Report 2017bseAnnual Report 2016bseAnnual Report 2015bseAnnual Report 2014bseAnnual Report 2013bseAnnual Report 2012bse
Concall transcripts56
TranscriptNov 2024PPTNov 2024TranscriptMay 2026RECMay 2026TranscriptJan 2026PPTJan 2026RECJan 2026TranscriptNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025PPTJun 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptAug 2024PPTAug 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024RECFeb 2024TranscriptDec 2023
Credit ratings6
Announcements5
Intimation Of Effective Date Of Scheme Of Amalgamation Of
J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders 8 Jul - JB Chemicals merged into Torrent Pharma effective 8 July 2026; appointed date 21 January 2026.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 JulRecord Date For The Purpose Of Determining The Shareholders Of The Company Who Shall Be Entitled To Receive Fully Paid-Up Equity Shares Of Torrent Pharma As Per The Share Exchange Ratio 7 Jul - Record date fixed for 17 July 2026 under JB Chemicals-Torrent Pharma amalgamation, ratio 51:100.Receipt Of Certified Copy Of Order Passed By National Company Law Tribunal, Ahmedabad Bench ('NCLT') Regarding The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders. 7 Jul - Certified copy received for NCLT order sanctioning JB Chemicals amalgamation with Torrent Pharmaceuticals on 6 July 2026.Pronouncement Of Final Order By The Hon'Ble National Company Law Tribunal, Ahmedabad Bench Sanctioning The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders 6 Jul - NCLT sanctioned J.B. Chemicals’ amalgamation with Torrent Pharmaceuticals on July 6, 2026.